En Rich Financial Partners LLC Exact Sciences Corp Transaction History
En Rich Financial Partners LLC
- $299 Billion
- Q3 2024
A detailed history of En Rich Financial Partners LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, En Rich Financial Partners LLC holds 328 shares of EXAS stock, worth $18,085. This represents 0.01% of its overall portfolio holdings.
Number of Shares
328
Previous 328
-0.0%
Holding current value
$18,085
Previous $13.9 Million
61.23%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding EXAS
# of Institutions
672Shares Held
163MCall Options Held
2.58MPut Options Held
2.19M-
Vanguard Group Inc Valley Forge, PA17.8MShares$980 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA15.8MShares$873 Million0.17% of portfolio
-
Wellington Management Group LLP Boston, MA14.3MShares$790 Million0.18% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$665 Million0.01% of portfolio
-
State Street Corp Boston, MA6.68MShares$368 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $9.76B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...